Stock AUGX AUGMEDIX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Augmedix, Inc.

Equities

AUGX

US05105P1075

Market Closed - Nasdaq
Other stock markets
 21:00:00 20/06/2024 BST 		5-day change 1st Jan Change
0.771 USD +2.80% Intraday chart for Augmedix, Inc. -3.75% -86.82%
06-20 Emergency Services Inc. Partners with Augmedix to Introduce Generative Ai Solution That Relieves Clinician Burnout in Emergency Departments CI
06-04 Augmedix, Inc. Reiterates Earnings Guidance for the Second Quarter and Full Year of 2024 CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Emergency Services Inc. Partners with Augmedix to Introduce Generative Ai Solution That Relieves Clinician Burnout in Emergency Departments
Augmedix, Inc. Reiterates Earnings Guidance for the Second Quarter and Full Year of 2024
Augmedix Appoints Alex Stinard as Chief Clinical AI Officer
Top Premarket Decliners
Investors Await Key Inflation Data as US Futures Tread Water in Premarket Session
Augmedix, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Augmedix, Inc. Provides Revenue Guidance for the Year 2024
Augmedix Launches Industry's First Fully-Automated, GenAI-Powered, Medical Documentation Product for Emergency Departments
Augmedix Insider Sold Shares Worth $369,285, According to a Recent SEC Filing
Augmedix, Inc. Integrates with Andor Health to Revolutionize Ambient Clinical Documentation for Ambulatory Virtual Care
Augmedix Insider Sold Shares Worth $454,454, According to a Recent SEC Filing
Augmedix Insider Sold Shares Worth $380,108, According to a Recent SEC Filing
Augmedix and SADA Forge Partnership to Scale Ambient Documentation and Structured Data Products to Health Systems Nationwide
Top Midday Gainers
Augmedix, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Augmedix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Augmedix Provides Revenue Guidance for the Year 2024
Augmedix Announces New Positive Data and Enhancements to Its Ambient AI Product, Augmedix Go
Augmedix Names Tomer Levy as New Senior Vice President of Engineering
Augmedix, Inc. Revises Revenue Guidance for the Fourth Quarter and Full Year Ended December 31, 2023
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AUGX Stock
  4. News Augmedix, Inc.
  5. Other languages